RxSight, Inc (RXST) insider trading
Every open-market stock purchase and sale by RxSight, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: Jesse Anderson Corley (Insider), $55K, 20 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales). Last close $5.20 on Sep 18, 2026.
Recent RXST insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 15, 2026 | Eric Weinberg (Insider) | Bought (not open market) | — |
| Jun 17, 2026 | Shweta Maniar (Insider) | Bought (not open market) | — |
| Jun 17, 2026 | Julie Andrews (Insider) | Bought (not open market) | — |
| Jun 17, 2026 | Raymond W Cohen (Insider) | Bought (not open market) | — |
| Jun 17, 2026 | Jesse Anderson Corley (Insider) | Bought (not open market) | — |
| Jun 17, 2026 | Tamara Fountain (Insider) | Bought (not open market) | — |
| Jun 17, 2026 | William J Link Phd (Insider) | Bought (not open market) | — |
| Jun 17, 2026 | Robert J Palmisano (Insider) | Bought (not open market) | — |
| Jun 17, 2026 | Bakker Juliet Tammenoms (Insider) | Bought (not open market) | — |
| Jun 17, 2026 | Robert Keith Warner (Insider) | Bought (not open market) | — |
| Apr 17, 2026 | Ilya Goldshleger (COO) | Bought (not open market) | — |
| Feb 28, 2026 | Mark Wilterding (CFO) | Sold (not open market) | $61.4K |
| Feb 28, 2026 | Scott Gaines (C-suite exec) | Sold (not open market) | $19.6K |
| Feb 28, 2026 | Scott Gaines (C-suite exec) | Bought (not open market) | — |
| Feb 28, 2026 | Scott Gaines (C-suite exec) | Bought (not open market) | — |
| Feb 28, 2026 | Scott Gaines (C-suite exec) | Bought (not open market) | — |
| Feb 28, 2026 | Scott Gaines (C-suite exec) | Bought (not open market) | — |
| Feb 28, 2026 | Mark Wilterding (CFO) | Bought (not open market) | — |
| Feb 28, 2026 | Scott Gaines (C-suite exec) | Bought (not open market) | — |
| Feb 27, 2026 | Scott Gaines (C-suite exec) | Bought (not open market) | — |
| Feb 27, 2026 | Eric Weinberg (Insider) | Bought (not open market) | — |
| Feb 27, 2026 | Ilya Goldshleger (COO) | Bought (not open market) | — |
| Feb 27, 2026 | Ronald M Kurtz MD (CEO) | Bought (not open market) | — |
| Jan 12, 2026 | Mark Wilterding (CFO) | Bought (not open market) | — |
| Jan 12, 2026 | Mark Wilterding (CFO) | Bought (not open market) | — |
Who's trading RXST
- Eric Weinberg, C-suite exec: other filings, last Sep 15, 2026
- Raymond W Cohen, Insider: other filings, last Jun 17, 2026
- Jesse Anderson Corley, Insider: other filings, last Jun 17, 2026
- Tamara Fountain, Insider: other filings, last Jun 17, 2026
- Julie Andrews, Insider: other filings, last Jun 17, 2026
- William J Link Phd, Insider: other filings, last Jun 17, 2026
- Shweta Maniar, Insider: other filings, last Jun 17, 2026
- Robert J Palmisano, Insider: other filings, last Jun 17, 2026
- Bakker Juliet Tammenoms, Insider: other filings, last Jun 17, 2026
- Robert Keith Warner, Insider: other filings, last Jun 17, 2026
- Ilya Goldshleger, Insider: other filings, last Apr 17, 2026
- Scott Gaines, C-suite exec: other filings, last Feb 28, 2026
- Mark Wilterding, CFO: other filings, last Feb 28, 2026
- Ronald M Kurtz MD, CEO: other filings, last Feb 27, 2026
Get free alerts when an insider at RxSight, Inc files a new trade →